June 21 | 2018
2cureX presents positive clinical data from its IndiTreat® CRC trial at ESMO in Barcelona
Read more
June 21 | 2018
2cureX presenterar positiva kliniska data från den kliniska studien med IndiTreat vid ESMO i Barcelona
Read more
May 29 | 2018
Clarification of warrants resolved at the Annual General Meeting
Read more
May 29 | 2018
Förtydligande om teckningsoptioner beslutade om på årsstämma
Read more
May 29 | 2018
Kommuniké från årsstämma i 2cureX AB (publ)
Read more
May 24 | 2018
Universitetssjukhuset Rigshospitalet, University Medical Center Hamburg-Eppendorf och 2cureX har inlett en studie avseende äggstockscancer
Read more
May 24 | 2018
The University Hospital, Rigshospitalet, University Medical Center Hamburg-Eppendorf and 2cureX have initiated a clinical study in ovarian cancer
Read more
May 18 | 2018
2cureX AB publishes interim report for the first financial quarter of 2018
Read more
May 18 | 2018
2cureX AB offentliggör delårsrapport för första kvartalet 2018
Read more
May 7 | 2018
2cureX AB offentliggör årsredovisning för räkenskapsåret 2017
Read more
May 7 | 2018
2cureX AB publishes annual report for the fiscal year 2017
Read more
May 4 | 2018
2cureX releases new information brochure
Read more
May 4 | 2018
2cureX publicerar idag en ny informationsbroschyr
Read more
May 2 | 2018
2cureX:s VD deltar på Folkemødet 2018 i Danmark
Read more
May 2 | 2018
2cureX’s CEO Ole Thastrup will join Folkemødet 2018 in Denmark
Read more
April 25 | 2018
Kallelse till årsstämma i 2cureX AB (publ)
Read more
April 24 | 2018
2cureX utvidgar sin verksamhet genom att öppna ett screeninglab vid Centrum für innovative Medizin (CiM) i Hamburg
Read more
April 24 | 2018
2cureX is expanding its operations in Germany with the opening of a screening lab at Centrum für innovative Medizin (CiM), Hamburg
Read more